Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP-binding cassette transporter sub-family C member 9 (ABCC9/SUR2), also known as sulfonylurea receptor 2 (SUR2), is a regulatory subunit of ATP-sensitive potassium (K-ATP) channels. These channels link cellular metabolism to membrane excitability, and ABCC9/SUR2 plays a crucial role in regulating their activity. It is expressed in various tissues, including cardiac muscle, skeletal muscle, and smooth muscle, and mutations in ABCC9 are associated with Cantú syndrome, familial atrial fibrillation, and intellectual disability/myopathy syndrome. It is a target of drugs such as sulfonylureas and vasodilators.
Modulation of K-ATP channel opening via direct interaction with the SUR subunit
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-binding cassette transporter sub-family C member 9 (ABCC9/SUR2).